Skip to main content


U.S. flag
      An official website of the United States government
              Here’s how you know
        Here’s how you knowDot gov**Official websites use .gov**
                 A **.gov** website belongs to an official government organization in the United States.
                  HTTPS**Secure .gov websites use HTTPS**
                 A **lock** (A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. 
  Menu Close
          HHS Search (ash)
    Search
        








  
  
    

  
      

                                      About HHS
    
                        
                              
      
      
      Programs & Services
    
                        
                              
      
      
      Grants & Contracts
    
                        
                              
      
      
      Laws & Regulations                  
Office of the Assistant Secretary for Health
  About OASH
    
                        
                                            
      
      
      Public Health Offices
    
                        
                                            
      
      
      Advisory Committees

              

    



Breadcrumb
    HHS
                              ASH Home
                              Office of Science and Medicine
                              InnovationX
                              Lyme Innovation


    

    

    Navigate to:
  Office of Science and Medicine
    
                                                  
                                                                  
            
      
      
      
      Chief Medical Officer
                                            
            
            Initiative on Substance Exposure in the Mother-Infant Dyad
    
                                                  
                                                                                        
                          
      
      
      
      InnovationX
                                            
            
            Covid-19 Data Driven Innovation
    
                                                                
                                                                  
            
      
      
      
      Human-Centered Design
                          
            
            Clinical Response through Emerging Technology (CRET)
    
                                                  
                                            
            
      
      
      
      Sickle Cell Disease
    
                                                  
                                            
            
      
      
      
      KidneyX
    
                                                                
                                                                                        
                          
      
      
      
      Lyme Innovation
                          
            
            Lyme Innovation: Real-World Impact
    
                                                  
                                            
            
      
      
      
      LymeX
    
                                                  
                                            
            
      
      
      
      PandemicX
    
                                                                
                                                                  
            
      
      
      
      Vector-Borne Disease National Strategy
                          
            
            Public Engagement
    
                                                  
                                            
            
      
      
      
      The Kay Hagan Tick Act
    
                                    
                                            
            
      
      
      
      LeadershipText resize icon

                    




Lyme Innovation








  
  
    

  
      





Read the 2024 Lyme Innovation Initiative and LymeX Innovation Accelerator Multi Year Plan to Change the Lyme Disease Status QuoThe Lyme Innovation initiative aims to accelerate innovation in the prevention, diagnosis, and treatment of tick-borne diseases through the development of next-gen technologies, interdisciplinary collaborations, and data-driven innovations for tick-borne
The HHS Lyme Innovation initiative is a patient-centered, data-driven approach to addressing the serious threat of Lyme disease and other tick- and vector-borne illnesses.Lyme disease affects more than 476,000 people in the United States each year, and that number is growing. The geographic spread of the disease is also growing due to the changing climate and other factors. Lyme disease accounts for more than 70% of all vector-borne illnesses in our country. Lyme and other tickborne conditions cost the U.S. economy billions of dollars annually.By supporting interdisciplinary collaborations that reflect the initiative’s core principles, Lyme Innovation is:Building commitment to data-driven, patient-centered innovations that improve outcomes.Identifying ways to better collect and share data while raising awareness of tickborne illnesses.Accelerating discovery of next-generation diagnostic tools and technologies.Lowering barriers across all phases of development, testing, and implementation.Lyme Innovation at a glanceLaunched on November 20, 2018 by HHS.Awarded $1 million through the LymeX Diagnostics Prize.Hosted roundtables, interviews, listening sessions, and workshops with patients, advocates, providers, clinicians, researchers, and policy makers.Lyme Innovation is catalyzing change through three strategic prioritiesEngage stakeholders to facilitate patient-centered innovationsLyme Innovation grounds advancements in lived experience through listening sessions, roundtables, and other learning approaches.Advance education and awarenessLyme Innovation fosters the development of new, community-based education and prevention efforts.Foster breakthroughs in next-generation diagnosticsLyme Innovation runs open innovation programs that incentivize and reduce risk for development.A Call for Innovators and Breakthrough SolutionsThrough strategic partnerships, Lyme Innovation is accelerating patient-centered advancements in addressing Lyme and other tickborne diseases.*May 2024*—Lyme Innovation Initiative and LymeX Innovation Accelerator Multi Year Plan to Change the Lyme Disease Status Quo*February 2024*—HHS announces winners of Phase 2 of the LymeX Diagnostics Prize Competitions*January 2023*—Phase 2 of the LymeX Diagnostics Prize launches, inviting the 10 Phase 1 winners to participate in the Phase 2 virtual accelerator.*May 2022*—Phase 1 of the LymeX Diagnostics Prize launches, seeking innovative methods for detecting active Lyme disease infections in people. The first phase awards $1 million in prizes across 10 winners.*December 2021*—Lyme Innovation announces new government partnerships in support of LymeX. Interagency agreements with the NASA Center of Excellence for Collaborative Innovation (CoECI) and the Defense Advanced Research Projects Agency (DARPA) aim to address the complex challenges presented by Lyme.*June 2021*—Lyme Innovation hosts the LymeX Education and Awareness Healthathon, calling on the public to create educational materials that help raise awareness about symptoms of Lyme disease and medical care. Submissions are accepted from June 17 to July 20, 2021, and Lyme Innovation names five winners.*February 2021*—Lyme Innovation releases the Accelerating Innovation in Diagnostic Testing for Lyme Disease Request for Information (RFI) to understand the current landscape and emerging technologies to improve Lyme disease diagnostics. The RFI receives 32 responses from the public on how research and investments in rapidly developed COVID-19 diagnostics might be adapted or repurposed for Lyme and tickborne diseases.*January 2021*—Health+ Lyme Disease program cycle launches. In support of LymeX, the Health+ Lyme Disease program cycle carries out a series of research and prototyping cycles aimed at surfacing insights, stories, journeys, and opportunities around the experiences of people living with Lyme disease. The Health+ Lyme Disease team completes nearly 700 hours of interviews, listening sessions, and workshops.*October 2020*—HHS and the Steven & Alexandra Cohen Foundation announce the $25 million LymeX Innovation Accelerator (LymeX), the largest Lyme disease public-private partnership in history. As a component of a larger moonshot, LymeX is identifying, developing, and implementing advancements in Lyme disease care—including next-generation diagnostics.To learn more about LymeX prize competitions and how to get involved, visit Lyme-X.org.The ApproachThe HHS Lyme Innovation initiative sees patients as more than the recipients of new prevention, diagnostic, and treatment tools and techniques to address Lyme disease and other tickborne illnesses. Patients are the driving forces of innovation, and their lived experiences inform our roadmap.Lyme Innovation’s guiding principles are**Accountability –**The buck stops here.**Collaboration –**Citizens and patients are equal partners.**Compassion –**Finding solutions to relieve suffering.**Excellence –**Quality, real-world evidence underlies decision-making.**Honesty/Integrity –**Find the truth. Tell the truth.**Innovation –**Shifting paradigms. Finding a better way.**Respect –**Everyone is valued.Additional InformationPress Releases and Blog PostsPhase 2 Winners in LymeX Diagnostics Prize announced (February 6, 2024)“HHS Shines Spotlight on Diagnostic Innovation During Lyme Disease Awareness Month” (May 3, 2023)Phase 2 of the LymeX Diagnostics Prize announced (February 2, 2023)Phase 1 Winners in LymeX Diagnostics Prize announced (November 9, 2022)Phase 1 of the LymeX Diagnostics Prize receives over 50 submissions (September 26, 2022)Phase 1 of the LymeX Diagnostics Prize launched (May 18, 2022)New LymeX government partnerships announced (December 27, 2021)“LymeX Exemplifies the Power of Partnerships after One Year of Progress” (October 20, 2021)LymeX announced (October 10, 2020)11 “TOP Health” Tech Sprint teams announced (January 7, 2019)Lyme Innovation initiative launched (November 20, 2018)External WebsitesLymeXLymeX Diagnostics PrizeVector-Borne Disease National StrategyVisit Lyme-X.org.
                        Lyme Innovation: Real-World ImpactLyme Innovation developments that are already making an impact on tick-borne illnesses




LymeXPublic-private partnership between HHS and the Steven & Alexandra Cohen Foundation to accelerate innovation in prevention efforts, diagnostics, and treatments for Lyme and other tick-borne diseases
                        Tick-Borne Diseases Working GroupWorking Group that reviews federal tick-borne disease efforts and research priorities, including Lyme Innovation, while ensuring interagency coordination




KidneyXPublic-private partnership between HHS and the American Society of Nephrology to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases

                    
  


Content created by Assistant Secretary for Health (ASH) Content last reviewed May 16, 2024Back to top
    Contact HHS
    
                        
                                            
      
      
      Careers
    
                        
                                            
      
      
      HHS FAQs
    
                        
                                            
      
      
      Nondiscrimination NoticeHHS Archive
    
                        
                                            
      
      
      Accessibility Statement
    
                        
                                            
      
      
      Privacy Policy
    
                        
                                            
      
      
      Viewers & PlayersBudget/Performance
    
                        
                                            
      
      
      Inspector General
    
                        
                                            
      
      
      Web Site Disclaimers
    
                        
                                            
      
      
      EEO/No Fear ActFOIA
    
                        
                                            
      
      
      The White House
    
                        
                                            
      
      
      USA.gov
    
                        
                                            
      
      
      Vulnerability Disclosure Policy
        Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
  HHS Headquarters
          200 Independence Avenue, S.W.
                  Washington, D.C. 20201
                  Toll Free Call Center: 1-877-696-6775​Disclaimer Policy: Links with this icon () mean that you are leaving the HHS website.
              The Department of Health and Human Services (HHS) cannot guarantee the accuracy of a non-federal website.
                  Linking to a non-federal website does not mean that HHS or its employees endorse the sponsors, information, or products presented on the website. HHS links outside of itself to provide you with further information.
                  You will be bound by the destination website's privacy policy and/or terms of service when you follow the link.
                  HHS is not responsible for Section 508 compliance (accessibility) on private websites.For more information on HHS's web notification policies, see Website Disclaimers.
              Continue
                  Go back